{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:54:26Z","timestamp":1791564866711,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["824RC500"],"award-info":[{"award-number":["824RC500"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005693","name":"Hainan University","doi-asserted-by":"publisher","award":["KYQD(ZR)23002"],"award-info":[{"award-number":["KYQD(ZR)23002"]}],"id":[{"id":"10.13039\/501100005693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22567014"],"award-info":[{"award-number":["22567014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22367007"],"award-info":[{"award-number":["22367007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179320","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:46:32Z","timestamp":1788619592000},"page":"179320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"1034","author":[{"given":"Zhe","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghuai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejphar.2026.179320_bib1","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/acschemneuro.2c00583","article-title":"Zebrafish as an experimental and preclinical model for Alzheimer's disease","volume":"13","author":"Bhattarai","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2169682","article-title":"Design, synthesis and evaluation of quinoline-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"38","author":"Chen","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115253","article-title":"Development of the \"hidden\" multi-target-directed ligands by AChE\/BuChE for the treatment of Alzheimer's disease","volume":"251","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179320_bib4","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.1080\/07391102.2023.2274518","article-title":"Integrated in-silico and in-vitro assessments of HDAC6 inhibitor efficacy in mitigating amyloid beta pathology in Alzheimer's disease","volume":"42","author":"Choudhary","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"21","key":"10.1016\/j.ejphar.2026.179320_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111677","article-title":"Glutamate and GABA in Microglia-Neuron cross-talk in Alzheimer's Disease","volume":"22","author":"Czapski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179320_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"7715","key":"10.1016\/j.ejphar.2026.179320_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/d41586-018-05717-6","article-title":"Alzheimer's disease","volume":"559","author":"Hodson","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179320_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179320_bib10","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s00018-015-1934-y","article-title":"Whole transcriptome analysis with sequencing: methods, challenges and potential solutions","volume":"72","author":"Jiang","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2009.09.005","article-title":"Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35)","volume":"221","author":"Kaminsky","year":"2010","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179320_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-024-03196-1","article-title":"Development of novel chalcone derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"33","author":"Li","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejphar.2026.179320_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113874","article-title":"Inhibition of histone deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: a review (2010-2020)","volume":"226","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108245","article-title":"Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD","volume":"157","author":"Li","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179320_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-024-03250-y","article-title":"Development of novel fluoro-substituted rivastigmine derivatives as selective AChE inhibitors for the treatment of AD","volume":"33","author":"Liu","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejphar.2026.179320_bib16","article-title":"A novel Zebrafish model of Alzheimer's disease by Aluminium chloride; involving nitro-oxidative stress, neuroinflammation and cholinergic pathway","volume":"965","author":"Nadiga Apr","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179320_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s10534-026-00788-9","article-title":"Unraveling the molecular mechanisms of aluminium chloride-induced Alzheimer's disease","author":"Paul","year":"2026","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib18","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1038\/s41598-023-34183-y","article-title":"Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-alzheimer's drugs","volume":"13","author":"Prasansuklab","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179320_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119275","article-title":"Histone deacetylase-6 modulates Tau function in Alzheimer's disease","volume":"1869","author":"Qureshi","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2026.179320_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106007","article-title":"Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-alzheimer's agents: design, synthesis, in vitro biological evaluation, in vivo and in silico studies","volume":"127","author":"Sang","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179320_bib28","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","article-title":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease","volume":"15","author":"Sang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179320_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","article-title":"Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease","volume":"23","author":"Sang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112265","article-title":"Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"194","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114464","article-title":"Alzheimer's disease: updated multi-targets therapeutics are in clinical and in progress","volume":"238","author":"Sang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112180","article-title":"The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"192","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179320_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2019.07.021","article-title":"Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease","volume":"180","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179320_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111318","article-title":"Discovery of \u03b1-mangostin derivatives as novel PDE4 inhibitors for the treatment of Alzheimer's disease: an artificial intelligence-driven synergized strategy","volume":"37","author":"Sang","year":"2026","journal-title":"Chin. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179320_bib29","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1021\/acs.jmedchem.4c02560","article-title":"AI-driven discovery of highly specific and efficacious hCES2A inhibitors for ameliorating irinotecan-triggered gut toxicity","volume":"68","author":"Sang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-024-01429-1","article-title":"Ganoderic acid a alleviates Abeta(25-35)-induced HT22 cell apoptosis through the ERK\/MAPK pathway: a system pharmacology and in vitro experimental validation","volume":"40","author":"Shao","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.179320_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jphotobiol.2016.02.028","article-title":"Pharmacological investigations and Petra\/Osiris\/Molinspiration (POM) analyses of newly synthesized potentially bioactive organotin(IV) carboxylates","volume":"158","author":"Tariq","year":"2016","journal-title":"J. Photochem. Photobiol., B"},{"issue":"6750","key":"10.1016\/j.ejphar.2026.179320_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.ady3217","article-title":"Predicting and preventing Alzheimer's disease","volume":"388","author":"Topol","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib34","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","article-title":"An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline","volume":"11","author":"Trzeciakiewicz","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179320_bib35","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1038\/ncomms8781","article-title":"HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity","volume":"6","author":"Tsushima","year":"2015","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179320_bib36","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00221-024-06858-z","article-title":"HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP\/PS1 transgenic mice through HSP90-HSF1 pathway","volume":"242","author":"Wang","year":"2024","journal-title":"Exp. Brain Res."},{"issue":"16","key":"10.1016\/j.ejphar.2026.179320_bib37","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1021\/acs.jmedchem.4c01168","article-title":"Discovery of novel imidazo[1,2-a]pyridine-based HDAC6 inhibitors as an anticarcinogen with a cardioprotective effect","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179320_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-2012-120727","article-title":"The role of HDAC6 in Alzheimer's disease","volume":"33","author":"Zhang","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179320_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.110964","article-title":"Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease","volume":"37","author":"Zhang","year":"2026","journal-title":"Chin. Chem. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:18:37Z","timestamp":1791562717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0014299926008022"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179320","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179320"}}